Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Dive

Showing results (101-110 of 204) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancerAlison Backen, Andrew G Renehan, Andrew R Clamp, et al.
Scientific Reports|November 15, 2017
PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathwaysSrivatsava Naidu, Lei Shi, Peter Magee, et al.
Clinical Colorectal Cancer|February 15, 2015
Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal CancerMatthew G Krebs, Andrew G Renehan, Alison Backen, et al.
Journal of Proteome Research|February 18, 2012
Statistical considerations of optimal study design for human plasma proteomics and biomarker discoveryCong Zhou, Kathryn L Simpson, Lee J Lancashire, et al.
Science (New York, N.Y.)|March 17, 2022
Early detection of cancerDavid Crosby, Sangeeta Bhatia, Kevin M Brindle, et al.
British Journal of Cancer|June 29, 2016
Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumabCong Zhou, Andrew Clamp, Alison Backen, et al.
The Journal of Clinical Investigation|March 12, 2011
Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1Luke R E Harrison, Dimitra Micha, Martin Brandenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancerMatthew G Krebs, Robert Sloane, Lynsey Priest, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approachesMatthew G Krebs, Jian-Mei Hou, Robert Sloane, et al.
Ebiomedicine|October 2, 2015
Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive ValueMichael J Walker, Cong Zhou, Alison Backen, et al.
Pageof 21

Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancerAlison Backen, Andrew G Renehan, Andrew R Clamp, et al.
Scientific Reports|November 15, 2017
PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathwaysSrivatsava Naidu, Lei Shi, Peter Magee, et al.
Clinical Colorectal Cancer|February 15, 2015
Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal CancerMatthew G Krebs, Andrew G Renehan, Alison Backen, et al.
Journal of Proteome Research|February 18, 2012
Statistical considerations of optimal study design for human plasma proteomics and biomarker discoveryCong Zhou, Kathryn L Simpson, Lee J Lancashire, et al.
Science (New York, N.Y.)|March 17, 2022
Early detection of cancerDavid Crosby, Sangeeta Bhatia, Kevin M Brindle, et al.
British Journal of Cancer|June 29, 2016
Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumabCong Zhou, Andrew Clamp, Alison Backen, et al.
The Journal of Clinical Investigation|March 12, 2011
Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1Luke R E Harrison, Dimitra Micha, Martin Brandenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancerMatthew G Krebs, Robert Sloane, Lynsey Priest, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approachesMatthew G Krebs, Jian-Mei Hou, Robert Sloane, et al.
Ebiomedicine|October 2, 2015
Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive ValueMichael J Walker, Cong Zhou, Alison Backen, et al.
Pageof 21